Quantitative studies of the interaction of cholecalciferol (vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols
- 1 May 1979
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 179 (2) , 413-423
- https://doi.org/10.1042/bj1790413
Abstract
Cholecalciferol (vitamin D3) and its 25-hydroxy metabolite are transported in plasma bound to a specific protein, the binding protein for cholecalciferol and its metabolites (DBP). DBP is identical with the group-specific component (Gc) proteins, which are known to display genetic polymorphism. Studies were conducted to explore whether or not major differences in the transport of cholecalciferol and its biological metabolites might exist among persons with different Gc phenotypes. Detailed quantitative studies were first carried out on the interaction of 25(OH)D3 with DBP in 21 different samples of serum, representing eight different Gc phenotypes. The studies used a filter disc assay method that provided highly reproducible quantitative results with cholecalciferol-related sterols. The Gc phenotypes studied included the three common types (Gc 1-1, 2-1, and 2-2) and several uncommon genetic variants (Gc Ab-Ab, Ab-1, Ab-2, Chip-1, and Chip-2). The binding affinities for 25(OH)D3 observed with these different sera were all fairly similar to each other. More extensive studies were then conducted to compare the binding of four cholecalciferol-related sterols to each of three genetic variants of DBP, by using sera from homozygous persons with the Gc 1-1, Gc 2-2 and Gc Ab-Ab phenotypes. The ligands tested included cholecalciferol, 25(OH)D3, 1,25(OH)2D3, and 24(R) 25(OH)2D3. The affinities of the three genetic types of DBP/Gc protein were found to be similar for each of the four cholecalciferol-related sterols. The apparent association constants for 25(OH)D3 and 24,25(OH)2D3 were similar (approx. 1–2 × 10(8) M-1); lesser affinities were observed for 1,25(OH)2D3 (kA approx. 1 × 10(7) M-1) and for cholecalciferol (kA approx. 3–4 × 10(5) M-1). Thus the common genetic variants of DBP/Gc protein, and the uncommon genetic variants studied here, all appear to have similar binding properties for cholecalciferol and its several metabolites.This publication has 29 references indexed in Scilit:
- Assay of vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography.Clinical Chemistry, 1978
- Immunological and immunoassay studies of the binding protein for vitamin D and its metabolites in human serum.Journal of Clinical Investigation, 1977
- Radioimmunoassay of the binding protein for vitamin D and its metabolites in human serum: concentrations in normal subjects and patients with disorders of mineral homeostasis.Journal of Clinical Investigation, 1976
- 1,25-Dihydroxyvitamin D in Biological Fluids: A Simplified and Sensitive AssayScience, 1976
- Human Serum Binding Capacity and Affinity for 25-Hydroxyergocalciferol and 25-HydroxycholecalciferolJournal of Clinical Endocrinology & Metabolism, 1976
- Measurement of 25-hydroxyvitamin D3 in serum.Clinical Chemistry, 1976
- SEASONAL VARIATIONS IN SERUM 25-HYDROXYCHOLECALCIFEROL IN HEALTHY PEOPLEThe Lancet, 1974
- The variants of the group-specific component. A review of their distribution in human populations.1973
- 2 GENETIC VARIANTS OF GROUP-SPECIFIC COMPONENT OF HUMAN SERUM - GC CHIPPEWA AND GC ABORIGINE1963
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955